Sparsh hospital opens multi-organ transplant centre in Bengaluru
The new centre will comprise a team of 50 highly experienced specialists
The new centre will comprise a team of 50 highly experienced specialists
CEQUA’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
The artificial cornea is 100% made of non-biological materials and require no co-implantation of donor corneas and it is an ideal option for treating patients with corneal blindness
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training
The HALO AP platform was developed by Indica Labs to address the specific needs of anatomic pathology labs by supporting a wide range of tissue-based workflows, including primary diagnosis, secondary consults, tumour boards, clinical trials, synoptic reporting, quantitative analytics, and AI
Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform from target identification through patient selection. It will receive an upfront cash payment of US $ 100 million with the potential of US $ 5.2 billion in total milestones plus tiered royalties
Subscribe To Our Newsletter & Stay Updated